The Dimorphic Brain In Ischemic Stroke: How Sex And Age Shape Molecular Pathophysiology And Therapeutic Responsiveness
Stroke, a leading cause of disability and death, affects individuals differently based on their biological sex and age. Research shows that the brain’s reaction to a lack of blood flow, known as ischemic stroke, isn’t uniform; it varies significantly depending on whether someone is male or female and their age.
These differences stem from unique molecular and cellular processes that are specific to each sex and evolve throughout a person’s life. For instance, the ways in which brain cells die after a stroke can differ. In males, a specific type of programmed cell death called parthanatos is more prominent, while in premenopausal females, a different pathway involving caspases (a type of enzyme) is more common. Key cellular components like mitochondria, which are the powerhouses of cells, and certain metabolic pathways also play a central role in these sex-dependent vulnerabilities.
As women age and go through reproductive changes, such as menopause, the protective effects observed in younger females against stroke tend to diminish. This shift is linked to changes in gene regulation, a decline in mitochondrial function, and alterations in immune cells in the brain called microglia. Beyond the brain itself, other bodily systems, including inflammation pathways, specific immune cells, and even the gut microbiome (the community of bacteria in the intestines), also contribute to how stroke affects individuals in a sex-specific way.
This understanding highlights the need to move away from a one-size-fits-all approach to stroke treatment. Instead, a more personalized strategy, often referred to as “stratified precision medicine,” is crucial. This involves developing targeted therapies that consider an individual’s biological sex and age to achieve better recovery outcomes.
Source: link to paper